Immuron Ltd (IMRN) stock
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.88−0.03 (-3.52%)
Close on Nov 13, 2026Market cap $7.06MP/E –Yield –
Immuron EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2026 it was -1.24 AUD. The highest annual figure on record is 9.25 AUD in fiscal 2016.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -1.24 AUD | – |
| FY2025 | Jun 30, 2025 | -2.26 AUD | – |
| FY2024 | Jun 30, 2024 | -3.04 AUD | – |
| FY2023 | Jun 30, 2023 | -1.66 AUD | – |
| FY2022 | Jun 30, 2022 | -1.25 AUD | – |
| FY2021 | Jun 30, 2021 | -3.79 AUD | – |
| FY2020 | Jun 30, 2020 | -1.66 AUD | – |
| FY2019 | Jun 30, 2019 | -3.22 AUD | – |
| FY2018 | Jun 30, 2018 | -2.30 AUD | – |
| FY2017 | Jun 30, 2017 | -6.40 AUD | -169.2% |
| FY2016 | Jun 30, 2016 | 9.25 AUD | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?